to take away R.A.? People would think it's witchcraft." Zitnik's =ackground was in pharmaceuticals; at Amgen, he contributed to the development of Enbrel, a =heumatoid-arthritis drug that had $4.7 billion in sales last year, which made it No. 7 on =he industry's best-seller list. But the more he talke